Separation of antithrombin III variants by micellar electrokinetic chromatography

被引:11
|
作者
Dönges, R
Römisch, J
Stauss, H
Brazel, D
机构
[1] Aventis Pharma, Qual Operat, D-35001 Marburg, Germany
[2] Aventis Behring, Res, D-35002 Marburg, Germany
关键词
sample injection; antithrombins; glycoprotein; proteins; enzyme inhibitors; heparin;
D O I
10.1016/S0021-9673(01)00827-5
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The characterisation of proteins is still one of the most challenging analytical tasks in modern bioanalysis. Due to the complex structure of proteins, several analytical techniques are often required to get sufficient information. Antithrombin III (AT III), a high-molecular-mass plasma glycoprotein which is an important protease inhibitor and the main modulator of thrombin activity, circulates in plasma in two isoforms, the so-called AT III-alpha (90-95%) and -beta (5-10%). Micellar electrokinetic chromatography was used to analytically separate these AT III variants, which differ in their affinity to the polysaccharide heparin. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:307 / 313
页数:7
相关论文
共 50 条